Jarne Elleholm Copenhagen Life Science Advisors

Jarne Elleholm, Managing Partner, has more than 20 years' experience in the life science industries across Europe and US with a strong record of achievements in commercialization and fundraising of life science products and companies.

Prior to establishing Copenhagen Life Science Advisors he worked in the venture capital industry as partner in Vækstfonden and as Managing Partner in Inventure Capital. From 2005-07 he served as CEO of the biotech company Aresa A/S, where he built up the organization and completed an IPO raising more than DKK 50 million.

Prior experience includes European Vice President for Whatman International and CEO for Lundbeck Ltd. UK where he successfully launched several pharmaceutical products.

Jarne Elleholm currently serves as Chairman of the board of Scandinavian Micro Biodevices. Prior board positions include Action Pharma, FCMB (Chairman), Quantibact, RSP Systems (Chairman), Medotech (Chairman), Proxeon and Liplasome Pharma.

Jarne holds an M.Com from Copenhagen Business School and an MBA from INSEAD.